Cartesian Therapeutics (RNAC) Times Interest Earned (2016 - 2023)
Historic Times Interest Earned for Cartesian Therapeutics (RNAC) over the last 9 years, with Q3 2023 value amounting to -$10.26.
- Cartesian Therapeutics' Times Interest Earned fell 41476.25% to -$10.26 in Q3 2023 from the same period last year, while for Jun 2024 it was -$38.48, marking a year-over-year decrease of 15884.13%. This contributed to the annual value of -$30.5 for FY2023, which is 73595.86% down from last year.
- According to the latest figures from Q3 2023, Cartesian Therapeutics' Times Interest Earned is -$10.26, which was down 41476.25% from -$24.78 recorded in Q2 2023.
- Over the past 5 years, Cartesian Therapeutics' Times Interest Earned peaked at $19.38 during Q2 2022, and registered a low of -$79.84 during Q2 2020.
- Over the past 5 years, Cartesian Therapeutics' median Times Interest Earned value was -$11.08 (recorded in 2020), while the average stood at -$19.9.
- As far as peak fluctuations go, Cartesian Therapeutics' Times Interest Earned soared by 294921.72% in 2022, and later crashed by 41476.25% in 2023.
- Over the past 5 years, Cartesian Therapeutics' Times Interest Earned (Quarter) stood at -$37.52 in 2019, then skyrocketed by 70.48% to -$11.08 in 2020, then surged by 151.78% to $5.74 in 2021, then tumbled by 283.55% to -$10.53 in 2022, then rose by 2.51% to -$10.26 in 2023.
- Its Times Interest Earned was -$10.26 in Q3 2023, compared to -$24.78 in Q2 2023 and -$22.75 in Q1 2023.